Reynolds Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-8,900
Closed -$750K 139
2015
Q4
$750K Buy
8,900
+4,300
+93% +$357K 0.81% 29
2015
Q3
$385K Sell
4,600
-4,000
-47% -$338K 0.48% 71
2015
Q2
$718K Buy
8,600
+1,400
+19% +$107K 0.7% 31
2015
Q1
$523K Buy
7,200
+1,100
+18% +$78.3K 0.46% 60
2014
Q4
$421K Buy
+6,100
New +$412K 0.35% 97

Other funds holding LLY

Reynolds Capital Management's LLY Position: Q1 2016 in Review

Reynolds Capital Management sold out of Eli Lilly (LLY) in Q1 2016, closing a stake of 8,900 shares — an estimated $750K sold.

Reynolds Capital Management first reported a position in LLY in Q4 2014 and held it in 5 quarters. The position peaked at $750K in Q4 2015. 1,152 funds tracked by Wall St. Rank hold LLY as of Q1 2016.

  • Reynolds Capital Management reported no remaining Eli Lilly position as of Q1 2016 after selling out during the quarter.
  • Reynolds Capital Management sold 8,900 Eli Lilly shares in Q1 2016, an estimated $750K.
  • Reynolds Capital Management first reported a position in Eli Lilly in Q4 2014 and held it in 5 quarters.
  • Reynolds Capital Management's Eli Lilly position peaked at $750K in Q4 2015.
  • 1,152 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.

Based on Reynolds Capital Management's 13F filing for Q1 2016, filed 13 May 2016.